Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP86899.RAV5tRmUhdyrWQQAWHB_BNj7TEkoRn7NTA0o9LY9zkr1Q130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP86899.RAV5tRmUhdyrWQQAWHB_BNj7TEkoRn7NTA0o9LY9zkr1Q130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP86899.RAV5tRmUhdyrWQQAWHB_BNj7TEkoRn7NTA0o9LY9zkr1Q130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP86899.RAV5tRmUhdyrWQQAWHB_BNj7TEkoRn7NTA0o9LY9zkr1Q130_provenance.
- NP86899.RAV5tRmUhdyrWQQAWHB_BNj7TEkoRn7NTA0o9LY9zkr1Q130_assertion description "[These results suggest that GSTM4 polymorphisms are biomarkers for the prediction of cisplatin response. ABCC4 polymorphisms, as well as GSTT1 copy number, may also help to predict cisplatin response, but further validation is required. These results represent a step toward the individualized chemotherapy of lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86899.RAV5tRmUhdyrWQQAWHB_BNj7TEkoRn7NTA0o9LY9zkr1Q130_provenance.
- NP86899.RAV5tRmUhdyrWQQAWHB_BNj7TEkoRn7NTA0o9LY9zkr1Q130_assertion evidence source_evidence_literature NP86899.RAV5tRmUhdyrWQQAWHB_BNj7TEkoRn7NTA0o9LY9zkr1Q130_provenance.
- NP86899.RAV5tRmUhdyrWQQAWHB_BNj7TEkoRn7NTA0o9LY9zkr1Q130_assertion SIO_000772 20200426 NP86899.RAV5tRmUhdyrWQQAWHB_BNj7TEkoRn7NTA0o9LY9zkr1Q130_provenance.
- NP86899.RAV5tRmUhdyrWQQAWHB_BNj7TEkoRn7NTA0o9LY9zkr1Q130_assertion wasDerivedFrom gad-20130706 NP86899.RAV5tRmUhdyrWQQAWHB_BNj7TEkoRn7NTA0o9LY9zkr1Q130_provenance.
- NP86899.RAV5tRmUhdyrWQQAWHB_BNj7TEkoRn7NTA0o9LY9zkr1Q130_assertion wasGeneratedBy ECO_0000203 NP86899.RAV5tRmUhdyrWQQAWHB_BNj7TEkoRn7NTA0o9LY9zkr1Q130_provenance.
- gad-20130706 importedOn "2013-07-06" NP86899.RAV5tRmUhdyrWQQAWHB_BNj7TEkoRn7NTA0o9LY9zkr1Q130_provenance.